Vadastuximab talirine: mechanism of action and combination with hypomethylating agents
Are combination therapies more effective for the treatment of relapsed refractory CLL?
The importance of targeting proliferating and quiescent cells in CLL
Standardising CLL patient stratification globally
How the removal of macrophages from tissue can stop or slow down the progression of CLL